Literature DB >> 16528244

Vascular tone control in humans: insights from studies in Bartter's/Gitelman's syndromes.

L A Calò1.   

Abstract

Studies in patients with Bartter's and Gitelman's syndromes performed in the last 10 years have provided important insights into the mechanistic details of relevant pathways of angiotensin II signaling and vascular tone regulation, therefore making these syndromes a good human model to gain insight into the mechanisms responsible for maintaining/controlling vascular tone. Extensive studies of patients with Bartter's/Gitelman's syndromes have, in fact, shown biochemical abnormalities of angiotensin II short- and long-term cell signaling, which depict a mirror image of those found in hypertension. The information obtained from the study of this human model of altered vascular tone regulation show that it can be used to gather more general data and/or confirm mechanistic details of the cellular and biochemical events involved in the pathophysiology of vascular tone control and to shed light on the multiplicity of the angiotensin II signaling-related mechanisms responsible for the pathophysiology of hypertension and its long-term complication such as cardiovascular remodeling and atherogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16528244     DOI: 10.1038/sj.ki.5000253

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  11 in total

1.  [Anesthesiological management of Gitelman syndrome : Teaching example on physiology and pathophysiology of electrolyte balance].

Authors:  E Schneck; S Schaumberg; C Koch; M Rickert; C Lichtenstern
Journal:  Anaesthesist       Date:  2013-08-10       Impact factor: 1.041

Review 2.  Angiotensin II and Cardiovascular-Renal Remodelling in Hypertension: Insights from a Human Model Opposite to Hypertension.

Authors:  Verdiana Ravarotto; Elisa Pagnin; Antonio Fragasso; Giuseppe Maiolino; Lorenzo A Calò
Journal:  High Blood Press Cardiovasc Prev       Date:  2015-03-11

Review 3.  Mechanistic approach to the pathophysiology of target organ damage in hypertension from studies in a human model with characteristics opposite to hypertension: Bartter's and Gitelman's syndromes.

Authors:  L A Calò; G Maiolino
Journal:  J Endocrinol Invest       Date:  2015-03-05       Impact factor: 4.256

Review 4.  Physiology and pathophysiology of SLC12A1/2 transporters.

Authors:  Nicolas Markadieu; Eric Delpire
Journal:  Pflugers Arch       Date:  2013-10-06       Impact factor: 3.657

5.  High angiotensin II state without cardiac remodeling (Bartter's and Gitelman's syndromes): are angiotensin II type 2 receptors involved?

Authors:  L A Calò; R Montisci; R Scognamiglio; P A Davis; E Pagnin; S Schiavo; P Mormino; A Semplicini; P Palatini; A D'Angelo; A C Pessina
Journal:  J Endocrinol Invest       Date:  2009-07-14       Impact factor: 4.256

6.  Relationship between NOX4 level and angiotensin II signaling in Gitelman's syndrome. Implications with hypertension.

Authors:  Lorenzo A Calò; Carmine Savoia; Paul A Davis; Elisa Pagnin; Verdiana Ravarotto; Giuseppe Maiolino
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 7.  Pathogenesis of calcineurin inhibitor-induced hypertension.

Authors:  Ewout J Hoorn; Stephen B Walsh; James A McCormick; Robert Zietse; Robert J Unwin; David H Ellison
Journal:  J Nephrol       Date:  2012 May-Jun       Impact factor: 3.902

8.  PLCβ1-SHP-2 complex, PLCβ1 tyrosine dephosphorylation and SHP-2 phosphatase activity: a new part of Angiotensin II signaling?

Authors:  Lorenzo A Calò; Luciana Bordin; Paul A Davis; Elisa Pagnin; Lucia Dal Maso; Gian Paolo Rossi; Achille C Pessina; Giulio Clari
Journal:  J Biomed Sci       Date:  2011-06-13       Impact factor: 8.410

9.  Gitelman syndrome, hypomagnesemia, and venous thrombosis: An intriguing association.

Authors:  Soumaya Chargui; Rawnak Houli; Mondher Ounissi; Fethi Ben Hamida; Amel Harzallah; Ezzeddine Abderrahim
Journal:  Clin Case Rep       Date:  2022-03-03

10.  Assessing the Relationship of Angiotensin II Type 1 Receptors with Erythropoietin in a Human Model of Endogenous Angiotensin II Type 1 Receptor Antagonism.

Authors:  Lorenzo A Calò; Paul A Davis; Giuseppe Maiolino; Elisa Pagnin; Verdiana Ravarotto; Elena Naso; Gianni Carraro; Agostino Naso
Journal:  Cardiorenal Med       Date:  2015-09-17       Impact factor: 2.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.